Advanced NSCLC Patients With T790M
1 clinical trials · Condition
◉ Watch Advanced NSCLC Patients With T790M
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Alflutinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer Patients With T790M (NCT03452592) | Allist Pharmaceuticals, Inc. | 2018-04-30 |
Track Advanced NSCLC Patients With T790M automatically
Every clearance here is in the API, with alerts when new ones post.